Biomedical Engineering Reference
In-Depth Information
In vitro
Vinblastine/
saquinavir
↓
Efflux
Inhibition of MRP2/Pgp
75
In vitro
Fexofenadine
↓
Uptake
Inhibition of OATP/oatp
25
In vitro
Estrone 3-sulfate
↓
Uptake
Inhibition of OATP-B
81
In vivo
Cyclosporine
↑
AUC,
↑
C
max
Inhibition of Pgp/CYP3A4
82-84
In vivo
Talinolol
↑
AUC,
↑
C
max
↓
AUC,
↓
C
max
Inhibition of Pgp
See the text
72
86
In vivo
Fexofenadine
↓
AUC,
↓
C
max
Inhibition of OATP
25,91
In vivo
Digoxin
↔
C
max
,
↔
AUC
See the text
87,88
Garlic
In vitro
Ritonavir
↓
Efflux
Inhibition of Pgp
48
In vitro
↓
Pgp protein level
96
In vivo
↓
Pgp protein level
96
In vivo
↑
Mrp2 protein level
97
↓
AUC,
↓
C
max
In vivo
Saquinavir/
ritonavir
Induction of Pgp/CYP3A4
98,99
Green tea
In vitro
Rhodamine 123
↑
Accumulation
Inhibition of Pgp
104
In vitro
Doxorubicin
↓
Efflux
Inhibition of Pgp
176
In vitro
↓
Pgp gene expression
↓
ATPase activity
105
In vitro
Methotrexate
↓
Efflux
Inhibition of MRP2
106
In vitro
Estrone 3-sulfate
↓
Uptake
Inhibition of OATP-B
110
(
Continued
)
Search WWH ::
Custom Search